Andrew H. Wei
- Molecular Biology top 0.5%
- Hematology top 0.05%
- Oncology top 0.5%
- Genetics top 0.5%
- Immunology top 1%
- Co-authors
- David C.S. HuangSimon N. WillisJerry M. AdamsCourtney D. DiNardoJamie I. FletcherAndrew W. RobertsCatherine L. DayPeter M. Colman
- Topics
- Acute Myeloid Leukemia Research (181 papers)Histone Deacetylase Inhibitors Research (51 papers)Chronic Myeloid Leukemia Treatments (44 papers)
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Andrew H. Wei
241 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Molecular Biology 7.4k
- Hematology 5.3k
- Oncology 2.8k
- Genetics 1.7k
- Immunology 1.6k
Countries citing papers authored by Andrew H. Wei
This map shows the geographic impact of Andrew H. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Wei more than expected).
Fields of papers citing papers by Andrew H. Wei
This network shows the impact of papers produced by Andrew H. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Wei. The network helps show where Andrew H. Wei may publish in the future.
Co-authorship network of co-authors of Andrew H. Wei
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew H. Wei. A scholar is included among the top collaborators of Andrew H. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew H. Wei. Andrew H. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 18 | |
| 6 | 7 | |
| 7 | 15 | |
| 8 | 10 | |
| 9 | 8 | |
| 10 | 83 | |
| 11 | 59 | |
| 12 | 42 | |
| 13 | 11 | |
| 14 | 75 | |
| 15 | 50 | |
| 16 | 10 | |
| 17 | 4 | |
| 18 | Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Studybreakdown → | 456 |
| 19 | 39 | |
| 20 | 68 |
About Andrew H. Wei
Andrew H. Wei is a scholar working on Hematology, Genetics and Oncology, having authored 258 papers that have together received 11.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (181 papers), Histone Deacetylase Inhibitors Research (51 papers) and Chronic Myeloid Leukemia Treatments (44 papers). The work is most often cited by research in Hematology (5.3k citations), Genetics (1.7k citations) and Molecular Biology (7.4k citations). Andrew H. Wei has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include David C.S. Huang, Simon N. Willis, Jerry M. Adams, Courtney D. DiNardo, Jamie I. Fletcher, Andrew W. Roberts, Catherine L. Day, Peter M. Colman, Marina Konopleva and Brenda Chyla. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.